Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of polyglutamate paclitaxel
when given together with carboplatin in treating patients with ovarian epithelial,
peritoneal, or fallopian tube cancer. Drugs used in chemotherapy such as polyglutamate
paclitaxel and carboplatin use different ways to stop tumor cells from dividing so they stop
growing or die. Polyglutamate paclitaxel may be able to deliver the drug directly to tumor
cells while leaving normal cells undamaged. Combining polyglutamate paclitaxel with
carboplatin may kill more tumor cells.